I have been thinking about AI a lot lately (I suspect most of us have). In addition to the general presence of AI in our lives, two recent events, neither of which occurred in Medtech, prompted this. The former is the letter the FDA issued last month to a pharma manufacturer (you can read the […]

Citeste mai mult